iomeprol has been researched along with Acute Generalised Exanthematous Pustulosis in 2 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Navarro Triviño, FJ | 1 |
Linares-González, L | 1 |
Ródenas-Herranz, T | 1 |
Llamas-Molina, JM | 1 |
Ruiz-Villaverde, R | 1 |
Machet, P | 1 |
Marcé, D | 1 |
Ziyani, Y | 1 |
Dumont, M | 1 |
Cornillier, H | 1 |
Jonville-Bera, AP | 1 |
Machet, L | 1 |
2 other studies available for iomeprol and Acute Generalised Exanthematous Pustulosis
Article | Year |
---|---|
Acute localized exanthematous pustulosis (ALEP) induced by iomeprol (Iomeron 350): A diagnostic challenge.
Topics: Acute Generalized Exanthematous Pustulosis; Contrast Media; Dermatitis, Allergic Contact; Female; Hu | 2021 |
Acute generalized exanthematous pustulosis induced by iomeprol with cross-reactivity to other iodinated contrast agents and mild reactions after rechallenge with iopromide and oral corticosteroid premedication.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Aged, 80 and over; Contrast Med | 2019 |